Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
13.55
+7.99 (143.71%)
At close: Nov 20, 2024, 4:00 PM
12.20
-1.35 (-9.96%)
Pre-market: Nov 21, 2024, 5:45 AM EST
Forte Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -34.2 | -31.48 | -13.88 | -21.71 | -46.49 | -4.07 | |
Depreciation & Amortization | 0.04 | 0.01 | - | 0.04 | 0.05 | 0.01 | |
Asset Writedown & Restructuring Costs | - | - | - | 0.06 | 30.89 | - | |
Loss (Gain) From Sale of Investments | 0.01 | -0.13 | - | - | - | - | |
Stock-Based Compensation | 3.18 | 3.28 | 4.02 | 4.21 | 0.96 | 0.04 | |
Change in Accounts Payable | -0.13 | 0.27 | 0.21 | -0.29 | -0.37 | 0.98 | |
Change in Other Net Operating Assets | 1.4 | -0.66 | 1.47 | 1.01 | -3.46 | 0.28 | |
Operating Cash Flow | -29.71 | -28.71 | -8.19 | -16.68 | -18.42 | -2.77 | |
Capital Expenditures | -0.02 | -0.09 | - | - | - | -0.16 | |
Cash Acquisitions | - | - | - | - | 3.58 | - | |
Investment in Securities | 0 | 0.14 | - | - | - | - | |
Investing Cash Flow | -0.02 | 0.05 | - | - | 3.58 | -0.16 | |
Issuance of Common Stock | - | 24.74 | 7.24 | 0.06 | 66.96 | - | |
Repurchase of Common Stock | -0.09 | -0.06 | - | - | - | - | |
Other Financing Activities | -0 | - | - | -0.11 | -0.29 | -0.04 | |
Financing Cash Flow | -0.1 | 24.68 | 7.24 | -0.04 | 66.67 | 4.86 | |
Net Cash Flow | -29.82 | -3.98 | -0.94 | -16.72 | 51.83 | 1.92 | |
Free Cash Flow | -29.73 | -28.79 | -8.19 | -16.68 | -18.42 | -2.93 | |
Free Cash Flow Per Share | -16.11 | -22.80 | -11.77 | -29.85 | -62.59 | -34.78 | |
Levered Free Cash Flow | -18.25 | -17.4 | -3.18 | -9.02 | -8.1 | -1.4 | |
Unlevered Free Cash Flow | -18.25 | -17.4 | -3.18 | -9.02 | -8.1 | -1.4 | |
Change in Net Working Capital | -0.72 | 0.3 | -1.49 | -0.16 | 0.22 | -1.25 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.